title: A postmenopausal woman with early-stage breast cancer and borderline hormone-receptor staining.
authors.affiliation: Division of Medical Oncology, Denver Health Medical Center, USA.
authors.forename: Alexander
authors.initials: A
authors.lastname: Urquhart
authors.forename: Virginia
authors.initials: V
authors.lastname: Borges
authors.forename: Rachel
authors.initials: R
authors.lastname: Rabinovitch
authors.forename: Meenakshi
authors.initials: M
authors.lastname: Singh
authors.forename: William
authors.initials: W
authors.lastname: Robinson
authors.forename: Paul
authors.initials: P
authors.lastname: Seligman
authors.forename: Jyoti
authors.initials: J
authors.lastname: Arya
authors.forename: Christina
authors.initials: C
authors.lastname: Finlayson
authors.forename: Anthony
authors.initials: A
authors.lastname: Elias
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001706:Biopsy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D044584:Carcinoma, Ductal / Q000188:drug therapy / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D008875:Middle Aged; D009367:Neoplasm Staging; D010347:Patient Care Planning; D017698:Postmenopause
chemical_list: D018931:Antineoplastic Agents, Hormonal